Related Experiment Video
Updated: Jun 25, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
A neurologist's guide to genome-wide association studies
S A Mullen1, D E Crompton, P W Carney
1Epilepsy Research Centre and Department of Medicine (Neurology), University of Melbourne, Austin Health, 145 Studley Rd., Heidelberg, Victoria 3084, Australia.
Genome-wide association studies (GWAS) identify genes for common diseases by comparing patient and control genotypes. This review explains GWAS, using epilepsy as an example, to guide interpretation of complex neurologic disease research.
Area of Science:
- Genetics
- Genomics
- Neurology
Background:
- Genome-wide association studies (GWAS) are powerful tools for discovering genes implicated in common diseases.
- Recent advances in genomics have made large-scale genetic association studies feasible and productive.
- These studies compare the genetic profiles of numerous unrelated patients with those of control groups.
Purpose of the Study:
- To provide an accessible introduction to the genetic and technical aspects of genome-wide association studies.
- To illustrate the application of GWAS in neurologic diseases using idiopathic generalized epilepsy as a case study.
- To highlight critical considerations such as phenotyping, sample size, and statistical methods in GWAS.
Main Methods:
- Review of current literature on genome-wide association studies and their application in disease gene discovery.
- Case study approach focusing on idiopathic generalized epilepsy to demonstrate practical challenges.
- Discussion of genetic principles and technical requirements for interpreting GWAS results.
Main Results:
- GWAS are increasingly yielding significant findings in common disease genetics.
- Application of GWAS to neurologic disorders, including epilepsy, is a rapidly growing field.
- Successful GWAS require careful attention to phenotyping, adequate sample sizes, and robust statistical analysis.
Conclusions:
- Genome-wide association studies are poised to revolutionize the understanding of complex neurologic diseases.
- Interpreting GWAS requires a solid foundation in genetics and an awareness of potential pitfalls.
- Future research will likely leverage GWAS to uncover novel genetic factors contributing to epilepsy and other neurologic conditions.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenomics: Identification of New Drug Targets
Genomics
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

